Syntara (FRA:UUDA) FCF Margin %: 0.00% (As of Dec. 2025)


What is Syntara FCF Margin %?

Syntara FRA:UUDA FCF Margin % is 0.00% as of Dec. 2025. The stock has 2 warning signs investors should review. Among 958 Drug Manufacturers companies, Syntara ranks worse than 104384.03% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Syntara's Free Cash Flow for the six months ended in Dec. 2025 was €-2.55 Mil. Syntara's Revenue for the six months ended in Dec. 2025 was €0.00 Mil. Therefore, Syntara's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Syntara's current FCF Yield % is -27.94%.

The historical rank and industry rank for Syntara's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of Syntara was 155.45%. The lowest was -366.09%. And the median was -124.47%.

FRA:UUDA's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.51
* Ranked among companies with meaningful FCF Margin % only.

Syntara FCF Margin % Related Terms

Syntara FCF Margin % Historical Data

* Premium members only.

The historical data trend for Syntara's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syntara FCF Margin % Chart

Syntara Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.28 -220.94 -128.62 0.00 0.00

Syntara Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:UUDA vs ZTS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Syntara's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syntara FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syntara's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Syntara's FCF Margin % falls into.


Syntara FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Syntara's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-6.274/0
= %

Syntara's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.551/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Syntara (FRA:UUDA) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Syntara and its competitors. According to the industry distribution chart, Syntara ranks #999999 out of 958 companies in the Drug Manufacturers industry.
Is Syntara's FCF Margin % too high?
Syntara's current FCF Margin % is 0.00%. Based on the distribution chart, Syntara ranks #999999 out of 958 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Syntara's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Syntara ranks #999999 out of 958 companies for FCF Margin %. This places Syntara in the lower half of its industry. The industry median FCF Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Syntara and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syntara's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syntara stock overvalued right now?
Based on GuruFocus' analysis, Syntara (FRA:UUDA) is currently considered Possible Value Trap. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 55% below its estimated fair value. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Syntara (FRA:UUDA), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Syntara Business Description

Other Exchanges SNT:Australia
Address 20 Rodborough Road, Unit 2, Frenchs Forest, Sydney, NSW, AUS, 2086
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring and neuroinflammation.